SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O'Malley BW 1987 Molecular cloning of complementary DNA encoding the avian receptor for vitamin D Science 235:12141217.
  • 2
    Haussler MR, Mangelsdorf DJ, Komm BS, Terpening CM, Yamaoka K, Allegretto EA, Baker AR, Shine J, McDonnell DP, Hughes M, Weigel NL, O'Malley BW, Pike JW 1988 Molecular biology of the vitamin D hormone Recent Prog Horm Res 44:263305.
  • 3
    Evans RM 1988 The steroid and thyroid hormone receptor superfamily Science 240:889895.
  • 4
    Holick MF 1996 Vitamin D and bone health J Nutr 126:1159S1164S.
  • 5
    MacDonald PN, Dowd DR, Haussler MR 1994 New insight into the structure and functions of the vitamin D receptor Sem Nephrol 14:101118.
  • 6
    Haussler MR, McCain TA 1977 Basic and clinical concepts related to vitamin D metabolism and action N Engl J Med 297:10411050.
  • 7
    Labuda M, Fujiwara TM, Ross MV, Morgan K, Garcia-Heras J, Ledbetter DH, Hughes MR, Glorieux FH 1992 Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13–14 J Bone Miner Res 7:14471453.
  • 8
    St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH 1997 The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus J Bone Miner Res 12:15521559.
  • 9
    Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S 1997 25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis Science 277:18271830.
  • 10
    Rut AR, Hewison M, Kristjansson K, Luisi B, Hughes MR, O'Riordan JLH 1994 Two mutations causing vitamin D resistant rickets: Modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures Clin Endocrinol 41:581590.
  • 11
    Whitfield GK, Selznick SH, Haussler CA, Hsieh J-C, Galligan MA, Jurutka PW, Thompson PD, Lee SM, Zerwekh JE, Haussler MR 1996 Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: Point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner Mol Endocrinol 10:16171631.
  • 12
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh J-C, Remus LS, Selznick SH, Whitfield GK 1997 The vitamin D hormone and its nuclear receptor: Molecular actions and disease states J Endocrinol 154:S57S73.
  • 13
    Malloy P, Eccleshall T, Gross C, Van Maldergem L, Bouillon R, Feldman D 1997 Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness J Clin Invest 99:297304.
  • 14
    Hewison M, Rut AR, Kristjansson K, Walker RE, Dillon MJ, Hughes MR, O'Riordan JL 1993 Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene Clin Endocrinol 39:663670.
  • 15
    Giraldo A, Pino W, Garcia-Ramirez LF, Pineda M, Iglesias A 1995 Vitamin D dependent rickets type II and normal vitamin D receptor cDNA sequence. A cluster in a rural area of Cauca, Colombia, with more than 200 affected children Clin Genet 48:5765.
  • 16
    Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S 1997 Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning Nat Genet 16:391396.
  • 17
    Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB 1997 Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia Proc Natl Acad Sci USA 94:98319835.
  • 18
    Li YC, Bergwitz C, Jüppner H, Demay MB 1997 Cloning and characterization of the vitamin D receptor from Xenopus laevis Endocrinology 138:23472353.
  • 19
    Li Y, Pirro A, Amling M, Baron R, Bronson R, Demay M 1997 Vitamin D receptor knock-out mice develop hypocalcemia, hyperparathyroidism, rickets, osteomalacia and alopecia J Bone Miner Res 12 (Suppl 1):S123 (abstract 81).
  • 20
    Balsan S, Garabedian M, Larchet M, Gorski AM, Cournot G, Tau C, Bourdeau A, Silve C, Ricour C 1986 Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D J Clin Invest 77:16611667.
  • 21
    al-Aqeel A, Ozand P, Sobki S, Sewairi W, Marx S 1993 The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII) Clin Endocrinol (Oxf) 39:229237.
  • 22
    Takeda S, Yoshizawa T, Fukumoto S, Nagai Y, Murayama H, Matsumoto T, Kato S, Fujita T 1997 Bone metabolism and in vitro osteoclast formation in VDR knock-out mice J Bone Miner Res 12 (Suppl 1):S110 (abstract 32).
  • 23
    Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M, Takahashi N, Suda T 1996 Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact Endocrinology 137:21872190.
  • 24
    Henry HL 1992 Vitamin D hydroxylases J Cellular Biochem 49:49.
  • 25
    Brumbaugh PF, Hughes MR, Haussler MR 1975 Cytoplasmic and nuclear binding components for 1α,25-dihydroxyvitamin D3 in chick parathyroid glands Proc Natl Acad Sci USA 72:48714875.
  • 26
    Hughes MR, Brumbaugh PF, Haussler MR, Wergedal JE, Baylink DJ 1975 Regulation of serum 1α,25-dihydroxyvitamin D3 by calcium and phosphate in the rat Science 190:578580.
  • 27
    Silver J, Russell J, Sherwood LM 1985 Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells Proc Natl Acad Sci USA 82:42704273.
  • 28
    Sugimoto T, Brown AJ, Ritter C, Morrissey J, Slatopolsky E, Martin KJ 1989 Combined effects of dexamethasone and 1,25-dihydroxyvitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells Endocrinology 125:638641.
  • 29
    Mackey SL, Heymont JL, Kronenberg HM, Demay MB 1996 Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid X receptor Mol Endocrinol 10:298305.
  • 30
    Reddy GS, Tserng KY 1989 Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway Biochemistry 28:17631769.
  • 31
    Tomon M, Tenenhouse HS, Jones G 1990 1,25-dihydroxyvitamin D3-inducible catabolism of vitamin D metabolites in mouse intestine Am J Physiol 258:G557G563.
  • 32
    Haussler MR, Pike JW, Dokoh S, Chandler JS, Chandler SK, Donaldson CA, Marion SL, 1982 1,25-dihydroxyvitamin D receptor in cultured cell lines: Occurrence, subcellular distribution and relationship to bioresponses. In: NormanAW, SchaeferK, HerrathDv, GrigoleitH–G, (eds.) Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism. Walter de Gruyter & Co., Berlin–New York, pp. 109113.
  • 33
    Ohyama Y, Ozono K, Uchida M, Shinki T, Kato S, Suda T, Yamamoto O, Noshiro M, Kato Y 1994 Identification of a vitamin D-responsive element in the 5′ flanking region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene J Biol Chem 269:1054510550.
  • 34
    St-Arnaud R, Arabian A, Travers R, Glorieux F, 1997 Abnormal intramembranous ossification in mice deficient for the vitamin D-24-hydroxylase gene. In: NormanA, BouillonR, ThomassetM, (eds.) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A., pp. 635639.
  • 35
    Henry HL, Norman AW 1978 Vitamin D: Two dihydroxylated metabolites are required for normal chicken egg hatchability Science 201:835837.
  • 36
    Nakamura T, Kurokawa T, Orimo H 1988 Increase of bone volume in vitamin D-repleted rats by massive administration of 24R,25(OH)2D3 Calcif Tissue Int 43:235243.
  • 37
    Schwartz Z, Dean DD, Walton JK, Brooks BP, Boyan BD 1995 Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3[24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3–responsive phenotype characteristic of growth zone chondrocytes Endocrinology 136:402411.
  • 38
    Seino Y, Nakamura T, Tanaka H, 1997 Role of 24R,25(OH)2D3 in bone formation. In: NormanAW, BouillonR, ThomassetM, (eds.) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A., pp. 640644.
  • 39
    DeMay MB, Kiernan MS, DeLuca HF, Kronenberg HM 1992 Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3 Proc Natl Acad Sci USA 89:80978101.
  • 40
    Tenenhouse HS 1997 Cellular and molecular mechanisms of renal phosphate transport J Bone Miner Res 12:159164.
  • 41
    Taketani Y, Miyamoto K, Tanaka K, Katai K, Chikamori M, Tatsumi S, Segawa H, Yamamoto H, Morita K, Takeda E 1997 Gene structure and functional analysis of the human Na+/phosphate co-transporter Biochem J 324:927934.
  • 42
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM 1980 Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia J Clin Invest 66:10201032.
  • 43
    Harrel RM, Lyles KW, Harrelson JM, Drezner MK 1985 Healing of bone disease in X-linked hypohosphatemic rickets/osteomalacia: Induction and maintenance with phosphorus and calcitriol J Clin Invest 75:18581868.
  • 44
    Francis F, Hennig S, Korn B, Reinhardt R, de Jong P, Poustka A, Lehrach H, Rowe PSN, Goulding JN, Summerfield T, Mountford R, Read AP, Popowska E, Pronicka D, Davies KE, O'Riordan JLH, Econs MJ, Nesbitt T, Drezner MK, Oudet C, Pannetier S, Hanauer A, Strom TM, Meindl A, Lorenz B, Cagnoli M, Mohnike KL, Murken J, Meitinger T 1995 A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets Nat Genet 11:130136.
  • 45
    Parker MS, Klein I, Haussler MR, Mintz DH 1981 Tumor-induced osteomalacia: Evidence for a surgically correctable alteration in vitamin D metabolism J Am Med Assoc 245:492493.
  • 46
    Nesbitt T, Coffman TM, Griffiths R, Drezner MK 1992 Crosstransplantation of kidneys in normal and hyp-mice: Evidence that the hyp-mouse phenotype is unrelated to an intrinsic renal defect J Clin Invest 89:14531459.
  • 47
    Meyer RA, Meyer MH, Gray RW 1989 Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice J Bone Miner Res 4:493500.
  • 48
    Econs MJ, Drezner MK 1994 Tumor-induced osteomalacia—Unveiling a new hormone N Engl J Med 330:16791681.
  • 49
    Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinmeister AR, Kumar R 1994 Inhibition of renal phosphate transport by a tumor product in a patient with oncogeneic osteomalacia N Engl J Med 330:16451649.
  • 50
    Rowe PS, Goulding JN, Francis F, Oudet C, Econs MJ, Hanauer A, Lehrach H, Read AP, Mountford RC, Summerfield T, Weissenbach J, Fraser W, Drezner MK, Davies KE, O'Riordan JL 1996 The gene for X-linked hypohosphataemic rickets maps to a 200–300 kb region in Xp22.1, and is located on a single YAC containing a putative vitamin D response element (VDRE) Hum Genet 97:345352.
  • 51
    Quesada JM, Martin-Malo A, Santiago J, Hervas F, Martinez ME, Castillo D, Barrio V, Aljama P 1990 Effect of calcitriol on insulin secretion in uraemia Nephrol Dial Transplant 5:10131017.
  • 52
    Smith EL, Pincus SH, Donovan L, Holick MF 1988 A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis J Am Acad Dermatol 19:516528.
  • 53
    Manolagas SC, Yu X-P, Girasole G, Bellido T 1994 Vitamin D and the hematolymphopoietic tissue: A 1994 update Sem Nephrol 14:129143.
  • 54
    Casteels K, Bouillon R, Waer M, Mathieu C 1995 Immunomodulatory effects of 1,25-dihydroxyvitamin D3 Curr Opin Nephrol Hypertens 4:313318.
  • 55
    Wientroub S, Winter CC, Wahl SM, Wahl LM 1989 Effect of vitamin D deficiency on macrophage and lymphocyte function in the rat Calcif Tissue Int 44:125130.
  • 56
    Lemire JM, Archer DC, Khulkarni A, Ince A, Uskokovic MR, Stephkowski S 1992 The vitamin D3 analogue 1,25-dihydroxy-Δ16-cholecalciferol prolongs the survival of murine cardiac allografts Transplantation 54:762763.
  • 57
    Lemire JM 1995 Immunomodulatory actions of 1,25-dihydroxyvitamin D3 J Steroid Biochem Mol Biol 53:599602.
  • 58
    Reitsma PH, Rothberg PG, Astrin SM, Trial J, Bar-Shavit Z, Hall A, Teitelbaum SL, Kahn AJ 1983 Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite Nature 306:492494.
  • 59
    Mangelsdorf DJ, Koeffler HP, Donaldson CA, Pike JW, Haussler MR 1984 1,25-dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): Receptor-mediated maturation to macrophage-like cells J Cell Biol 98:391398.
  • 60
    Branisteanu DD, Waer M, Sobis H, Marcelis S, Vandeputte M, Bouillon R 1995 Prevention of murine experimental allergic encephalomyelitis: Cooperative effects of cyclosporine and 1 alpha,25-(OH)2D3 J Neuroimmunol 61:151160.
  • 61
    Nataf S, Garcion E, Darcy F, Chabannes D, Muller JY, Brachet P 1996 1,25-dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis J Neuropathol Exp Neurol 55:904914.
  • 62
    Naveilhan P, Neveu I, Wion D, Brachet P 1996 1,25-dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor Neuroreport 7:21712175.
  • 63
    Furman I, Baudet C, Brachet P 1996 Differential expression of M-CSF, LIF, and TNF-alpha genes in normal and malignant rat glial cells: Regulation by lipopolysaccharide and vitamin D J Neurosci Res 46:360366.
  • 64
    Neveu I, Naveilhan P, Baudet C, Brachet P, Metsis M 1994 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes Neuroreport 6:124126.
  • 65
    Neveu I, Naveilhan P, Jehan F, Baudet C, Funakosi H, Wion D, Brachet P, Metsis M 1994 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells Brain Res 24:7076.
  • 66
    Saporito MS, Brown ER, Hartpence KC, Wilcox HM, Vaught JL, Carswell S 1994 Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain Brain Res 633:189196.
  • 67
    Sonnenberg J, Luine VN, Krey LC, Christakos S 1986 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei Endocrinology 118:14331439.
  • 68
    Dowd DR, MacDonald PN, Komm BS, Haussler MR, Miesfeld RL 1992 Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes Mol Endocrinol 6:18431848.
  • 69
    Airaksinen MS, Eilers J, Garaschuk O, Thoenen H, Konnerth A, Meyer M 1997 Ataxia and altered dendritic calcium signaling in mice carrying a targeted null mutation of the calbindin D28k gene Proc Natl Acad Sci USA 94:14881493.
  • 70
    Sutherland MK, Somerville MJ, Yoong LKK, Bergeron C, Haussler MR, McLachlan DRC 1992 Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: Correlation with calbindin-D28k mRNA levels Brain Res Mol Brain Res 13:239250.
  • 71
    Maguire-Zeiss KA, Li ZW, Shimoda LM, Hamill RW 1995 Calbindin-D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: Comparison between control and Alzheimer disease subjects Brain Res Mol Brain Res 30:362366.
  • 72
    Miyamoto K-I, Kesterson RA, Yamamoto H, Taketani Y, Nishiwaki E, Tatsumi S, Inoue Y, Morita K, Takeda E, Pike JW 1997 Structural organization of the human vitamin D receptor chromosomal gene and its promoter Mol Endocrinol 11:11651179.
  • 73
    Faraco JH, Morrison NA, Baker A, Shine J, Frossard PM 1989 ApaI dimorphism at the human vitamin D receptor gene locus Nucleic Acids Res 17:2150.
  • 74
    Laudet V, Begue A, Henry-Duthoit C, Joubel A, Martin P, Stehelin D, Saule S 1991 Genomic organization of the human thyroid hormone receptor α (c-erbA-1) gene Nucleic Acids Res 19:11051112.
  • 75
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles Nature 367:284287.
  • 76
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1997 Prediction of bone density from vitamin D receptor alleles [correction] Nature 387:106.
  • 77
    Riggs BL, Nguyen TV, Melton LJI, Morrison NA, O'Fallon WM, Kelly PJ, Egan KS, Sambrook PN, Muhs JM, Eisman JA 1995 The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women J Bone Miner Res 10:991996.
  • 78
    Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B 1995 The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women J Bone Miner Res 10:985990.
  • 79
    Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian J 1994 Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus J Clin Invest 94:21302134.
  • 80
    Barger-Lux MJ, Heaney RP, Hayes J, DeLuca HF, Johnson ML, Gong G 1995 Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density Calcif Tissue Int 57:161162.
  • 81
    Lim SK, Park YS, Park JM, Song YD, Lee EJ, Kim KR, Lee HC, Huh KB 1995 Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans J Clin Endocrinol Metab 80:36773681.
  • 82
    Garnero P, Borel O, Sornay-Rendu E, Delmas PD 1995 Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women J Bone Miner Res 10:12831288.
  • 83
    Houston LA, Grant SFA, Reid DM, Ralston SH 1996 Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: Studies in a UK population Bone 18:249252.
  • 84
    Cooper GS, Umbach DM 1996 Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis J Bone Miner Res 11:18411849.
  • 85
    Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour JP 1995 Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density [see comments] Lancet 345:423424.
  • 86
    Salamone LM, Ferrell R, Black DM, Palermo L, Epstein RS, Petro N, Steadman N, Kuller LH, Cauley JA 1996 The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women Osteoporos Int 6:6368. (published erratum appears in Osteoporos Int 1996;6:187-188).
  • 87
    Viitanen A, Karkkainen M, Laitinen K, Lamberg-Allardt C, Kainulainen K, Rasanen L, Viikari J, Valimaki MJ, Kontula K 1996 Common polymorphism of the vitamin D receptor gene is associated with variation of peak bone mass in young Finns Calcif Tissue Int 59:231234.
  • 88
    McClure L, Eccleshall TR, Gross C, Villa ML, Lin N, Ramaswamy V, Kohlmeier L, Kelsey JL, Marcus R, Feldman D 1997 Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women J Bone Miner Res 12:234240.
  • 89
    Feldman D 1997 Androgen and vitamin D receptor gene polymorphisms: The long and short of prostate cancer risk J Natl Cancer Inst 89:109111.
  • 90
    Carling T, Kindmark A, Hellman P, Holmberg L, Akerstrom G, Rastad J 1997 Vitamin D receptor alleles b, a, and T: Risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1 Biochem Biophys Res Commun 231:329332.
  • 91
    Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA 1996 Association of prostate cancer with vitamin D receptor gene polymorphism Cancer Res 56:41084110.
  • 92
    Ingles SA, Haile RW, Henderson BE, Kolonel LN, Nakaichi G, Shi CY, Yu MC, Ross RK, Coetzee GA 1997 Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: Implications for association studies Cancer Epidemiol Biomarkers Prev 6:9398.
  • 93
    Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA 1997 Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor J Natl Cancer Inst 89:166170.
  • 94
    Ingles S, Haile R, Henderson B, Kolonel L, Coetzee G, 1997 Association of vitamin D receptor genetic polymorphism with breast cancer risk in African-American and Hispanic women. In: NormanA, BouillonR, ThomassetM, (eds.) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A. pp. 813814.
  • 95
    Karran P 1996 Microsatellite instability and DNA mismatch repair in human cancer Semin Cancer Biol 7:1524.
  • 96
    Arai H, Miyamoto K-I, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E 1997 A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women J Bone Miner Res 12:915921.
  • 97
    Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D 1996 The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women J Bone Miner Res 11:18501855.
  • 98
    Witte SM, Rogers J 1997 The short or ‘F’ form of the vitamin D receptor appears to be of recent evolutionary origin and unique to humans J Bone Miner Res 12(Suppl 1):S371 (abstract F579).
  • 99
    MacDonald PN, Dowd DR, Nakajima S, Galligan MA, Reeder MC, Haussler CA, Ozato K, Haussler MR 1993 Retinoid X receptors stimulate and 9-cis retinoic acid inhibits, 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene Mol Cell Biol 13:59075917.
  • 100
    Cockerill FJ, Hawa NS, Yousaf N, Hewison M, O'Riordan JL, Farrow SM 1997 Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets J Clin Endocrinol Metab 82:31563160.
  • 101
    Hawa NS, Cockerill FJ, Vadher S, Hewison M, Rut AR, Pike JW, O'Riordan JL, Farrow SM 1996 Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping Clin Endocrinol 45:8592.
  • 102
    Rastinejad F, Perlmann T, Evans RM, Sigler PB 1995 Structural determinants of nuclear receptor assembly on DNA direct repeats Nature 375:203211.
  • 103
    Hsieh J-C, Shimizu Y, Minoshima S, Shimizu N, Galligan MA, Haussler CA, Haussler MR, 1998 Identification of a nuclear localization signal between the zinc fingers of the human vitamin D receptor. J Cellular Biochem (in press).
  • 104
    Hsieh J-C, Jurutka PW, Galligan MA, Terpening CM, Haussler CA, Samuels DS, Shimizu Y, Shimizu N, Haussler MR 1991 Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function Proc Natl Acad Sci USA 88:93159319.
  • 105
    Hsieh J-C, Jurutka PW, Nakajima S, Galligan MA, Haussler CA, Shimizu Y, Shimizu N, Whitfield GK, Haussler MR 1993 Phosphorylation of the human vitamin D receptor by protein kinase C: Biochemical and functional evaluation of the serine 51 recognition site J Biol Chem 268:1511815126.
  • 106
    Walters R, Hunziker W, Norman AW 1980 Unoccupied 1,25-dihydroxyvitamin D3 receptors J Biol Chem 255:67996805.
  • 107
    Clemens TL, Garrett KP, Zhou X-Y, Pike JW, Haussler MR, Dempster DW 1988 Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells Endocrinology 122:12241230.
  • 108
    Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW, Coombes RC 1988 Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues J Clin Endocrinol Metab 67:607613.
  • 109
    Milde P, Merke J, Ritz E, Haussler MR, Rauterberg EW 1989 Immunohistochemical detection of 1,25-dihydroxyvitamin D3 receptors and estrogen receptors by monoclonal antibodies: Comparison of four immunoperoxidase methods J Histochem Cytochem 37:16091617.
  • 110
    Zanello SB, Collins ED, Marinissen MJ, Norman AW, Boland RL 1997 Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts Horm Metab Res 29:231236.
  • 111
    Luo Z, Rouvinen J, Mäenpää PH 1994 A peptide C-terminal to the second Zn finger of human vitamin D receptor is able to specify nuclear localization Eur J Biochem 223:381387.
  • 112
    Simental JA, Sar M, Lane MV, French FS, Wilson EM 1991 Transcriptional activation and nuclear targeting signals of the human androgen receptor J Biol Chem 266:510518.
  • 113
    Guiochon-Mantel A, Loosfelt H, Lescop P, Sar S, Atger M, Perrot-Applanat M, Milgrom E 1989 Mechanisms of nuclear localization of the progesterone receptor: Evidence for interaction between monomers Cell 57:11471154.
  • 114
    Picard D, Yamamoto KR 1987 Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor EMBO J 6:33333340.
  • 115
    Barsony J, Renyi I, Mckoy W 1997 Subcellular distribution of normal and mutant vitamin D receptors in living cells J Biol Chem 272:57745782.
  • 116
    Saijo T, Ito M, Takeda E, Mahbubul Hug AHM, Naito E, Yokota I, Sone T, Pike JW, Kuroda Y 1991 A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: Utility of single stranded conformation polymorphism analysis for heterozygous carrier detection Am J Hum Genet 49:668673.
  • 117
    Sackey FNA, Haché RJG, Reich T, Kwast-Welfeld J, Lefebvre YA 1996 Determinants of subcellular distribution of the glucocorticoid receptor Mol Endocrinol 10:11911205.
  • 118
    Renaud J-P, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid Nature 378:681689.
  • 119
    Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor Nature 378:690697.
  • 120
    Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α Nature 375:377382.
  • 121
    Kristjansson K, Rut AR, Hewison M, O'Riordan JLH, Hughes MR 1993 Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25-dihydroxyvitamin D3 J Clin Invest 92:1216.
  • 122
    Jones BB, Jurutka PW, Haussler CA, Haussler MR, Whitfield GK 1991 Vitamin D receptor phosphorylation in transfected ROS 17/2.8 cells is localized to the N-terminal region of the hormone-binding domain Mol Endocrinol 5:11371146.
  • 123
    Nakajima S, Hsieh J-C, Jurutka PW, Galligan MA, Haussler CA, Whitfield GK, Haussler MR 1996 Examination of the potential functional role of conserved cysteine residues in the hormone binding domain of the human 1,25-dihydroxyvitamin D3 receptor J Biol Chem 271:51435149.
  • 124
    Nakajima S, Hsieh J-C, MacDonald PN, Galligan MA, Haussler CA, Whitfield GK, Haussler MR 1994 The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D responsive element Mol Endocrinol 8:159172.
  • 125
    Wurtz J-M, Guillot B, Moras D, 1997 3D model of the ligand binding domain of the vitamin D receptor based on the crystal structure of holo RARγ. In: NormanAW, BouillonR, ThomassetM, (eds.) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A. pp. 165172.
  • 126
    Nishikawa J, Kitaura M, Imagawa M, Nishihara T 1995 Vitamin D receptor contains multiple dimerization interfaces that are functionally different Nucleic Acids Res 23:606611.
  • 127
    Hsieh J-C, Jurutka PW, Selznick SH, Reeder MC, Haussler CA, Whitfield GK, Haussler MR 1995 The T-box near the zinc fingers of the human vitamin D receptor is required for heterodimeric DNA binding and transactivation Biochem Biophys Res Commun 215:17.
  • 128
    Rosen ED, Beninghof EG, Koenig RJ 1993 Dimerization interfaces of thyroid hormone, retinoic acid, vitamin D, and retinoid X receptors J Biol Chem 268:1153411541.
  • 129
    Whitfield GK, Hsieh J-C, Nakajima S, MacDonald PN, Thompson PD, Jurutka PW, Haussler CA, Haussler MR 1995 A highly conserved region in the hormone binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation Mol Endocrinol 9:11661179.
  • 130
    Jin CH, Kerner SA, Hong MH, Pike JW 1996 Transcriptional activation and dimerization functions in the human vitamin D receptor Mol Endocrinol 10:945957.
  • 131
    Henttu PM, Kalkhoven E, Parker MG 1997 AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors Mol Cell Biol 17:18321839.
  • 132
    Webster NJG, Green S, Jin JR, Chambon P 1988 The hormone binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function Cell 54:199207.
  • 133
    Danielian PS, White R, Lees JA, Parker MG 1992 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors EMBO J 11:10251033.
  • 134
    Saatcioglu F, Deng T, Karin M 1993 A novel cis element mediating ligand-independent activation by c-ErbA: Implications for hormonal regulation Cell 75:10951105.
  • 135
    Leng X, Blanco J, Tsai SY, Ozato K, O'Malley BW, Tsai M-J 1995 Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region Mol Cell Biol 15:255263.
  • 136
    Jurutka PW, Hsieh J-C, Remus LS, Whitfield GK, Thompson PD, Haussler CA, Blanco JCG, Ozato K, Haussler MR 1997 Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding and interaction with basal transcription factor IIB, in vitro J Biol Chem 272:1459214599.
  • 137
    Masuyama H, Brownfield CM, St-Arnaud R, MacDonald PN 1997 Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction Mol Endocrinol 11:15071517.
  • 138
    Haussler MR, Jurutka PW, Haussler CA, Hsieh J-C, Thompson PD, Remus LS, Selznick SH, Encinas C, Whitfield GK, 1997 VDR-mediated transactivation: Interplay between 1,25(OH)2D3, RXR heterodimerization, transcription (co)-factors and polymorphic receptor variants. In: NormanAW, BouillonR, ThomassetM, (eds.) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A. pp. 210217.
  • 139
    Haussler MR, Jurutka PW, Hsieh J-C, Thompson PD, Selznick SH, Haussler CA, Whitfield GK, 1994 Receptor mediated genomic actions of 1,25(OH)2D3: Modulation by phosphorylation. In: NormanAW, BouillonR, ThomassetM, (eds.) Vitamin D: A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. Walter de Gruyter, Berlin, Germany, pp. 209216.
  • 140
    Brown TA, DeLuca HF 1990 Phosphorylation of the 1,25-dihydroxyvitamin D3 receptor: A primary event in 1,25-dihydroxyvitamin D3 action J Biol Chem 265:1002510029.
  • 141
    Jurutka PW, Hsieh J-C, Haussler MR 1993 Phosphorylation of the human, 1,25-dihydroxyvitamin D3 receptor by cAMP-dependent protein kinase, in vitro, and in transfected COS-7 cells Biochem Biophys Res Commun 191:10891096.
  • 142
    Nakajima S, Yamagata M, Ozono K 1996 Effects of cyclic adenosine monophosphate and protein kinase-A on ligand-dependent transactivation via vitamin D receptor J Bone Miner Res 11(Suppl 1):S162 (abstract P287).
  • 143
    Jurutka PW, Hsieh J-C, MacDonald PN, Terpening CM, Haussler CA, Haussler MR, Whitfield GK 1993 Phosphorylation of serine 208 in the human vitamin D receptor: The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells J Biol Chem 268:67916799.
  • 144
    Hilliard GM, Cook RG, Weigel NL, Pike JW 1994 1,25-Dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: Site-directed mutagenesis of this residue promotes alternative phosphorylation Biochemistry 33:43004311.
  • 145
    Jurutka PW, Hsieh J-C, Nakajima S, Haussler CA, Whitfield GK, Haussler MR 1996 Human vitamin D receptor phosphorylation by casein kinase II at ser-208 potentiates transcriptional activation Proc Natl Acad Sci USA 93:35193524.
  • 146
    Taneja R, Rochette-Egly C, Plassat JL, Penna L, Gaub MP, Chambon P 1997 Phosphorylation of activation functions AF-1 and AF-2 of RARalpha and RARgamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment EMBO J 16:64526465.
  • 147
    Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW 1988 Cloning and expression of full-length cDNA encoding human vitamin D receptor Proc Natl Acad Sci USA 85:32943298.
  • 148
    Burmester JK, Wiese RJ, Maeda N, DeLuca HF 1988 Structure and regulation of the rat 1,25-dihydroxyvitamin D3 receptor Proc Natl Acad Sci USA 85:94999502.
  • 149
    Kamei Y, Kawada T, Fukuwatari T, Ono T, Kato S, Sugimoto E 1995 Cloning and sequencing of the gene encoding the mouse vitamin D receptor Gene 152:281282.
  • 150
    Haussler MR, Terpening CM, Jurutka PW, Meyer J, Schulman BA, Haussler CA, Whitfield GK, Komm BS, 1988 Vitamin D hormone receptors: Structure, regulation and molecular function. In: ImuraH, ShizumeK, YoshidaS, (eds.) Progress in Endocrinology. Elsevier Science Publishers B.V., Amsterdam, The Netherlands, pp. 763770.
  • 151
    Lu Z, Hanson K, DeLuca HF 1997 Cloning and origin of the two forms of chicken vitamin D receptor Arch Biochem Biophys 339:99106.
  • 152
    Colnot S, Lambert M, Blin C, Thomasset M, Perret C 1995 Identification of DNA sequences that bind retinoid X receptor-1,25(OH)2D3-receptor heterodimers with high affinity Mol Cell Endocrinol 113:8998.
  • 153
    Nishikawa J, Kitaura M, Matsumoto M, Imagawa M, Nishihara T 1994 Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer Nucleic Acids Res 22:29022907.
  • 154
    Jin CH, Pike JW 1996 Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor Mol Endocrinol 10:196205.
  • 155
    MacDonald PN, Haussler CA, Terpening CM, Galligan MA, Reeder MC, Whitfield GK, Haussler MR 1991 Baculovirus-mediated expression of the human vitamin D receptor: Functional characterization, vitamin D response element interactions, and evidence for a receptor auxiliary factor J Biol Chem 266:1880818813.
  • 156
    Staal A, van Wijnen AJ, Birkenhäger JC, Pols HA, Prahl J, DeLuca H, Gaub M-P, Lian JB, Stein GS, van Leeuwen JPTM, Stein JL 1996 Distinct conformations of vitamin D receptor/retinoid X receptor-α heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements for the osteocalcin and osteopontin genes Mol Endocrinol 10:14441456.
  • 157
    O'Connell TD, Simpson RU 1995 1,25-Dihydroxyvitamin D3 regulation of myocardial growth and c-myc levels in the rat heart Biochem Biophys Res Commun 213:5965.
  • 158
    Pan Q, Martell RE, O'Connell TD, Simpson RU, 1997 1,25-Dihydroxyvitamin D3 regulation of c–myc expression and MIE binding proteins during HL–60 cell differentiation. In: NormanAW, BouillonR, ThomassetM, (eds.) Vitamin D: Chemistry, Biology and Clinical Application of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A. pp. 306307.
  • 159
    Alroy I, Towers TL, Freedman LP 1995 Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor Mol Cell Biol 15:57895799.
  • 160
    Breen EC, van Wijnen AJ, Lian JB, Stein GS, Stein JL 1994 In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells Proc Natl Acad Sci USA 91:1290212906.
  • 161
    Koszewski NJ, Ashok S, Russell J 1996 Turning a negative into a positive: Mutation of the avian parathyroid hormone response element and vitamin D transcriptional activity J Bone Miner Res 11(Suppl 1):S115 (abstract 83).
  • 162
    Lian JB, Shalhoub V, Aslam F, Frenkel B, Green J, Hamrah M, Stein GS, Stein JL 1997 Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: Dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression Endocrinology 138:21172127.
  • 163
    Zhang R, Ducy P, Karsenty G 1997 1,25-dihydroxyvitamin D3 inhibits osteocalcin expression in mouse through an indirect mechanism J Biol Chem 272:110116.
  • 164
    Kurokawa R, Söderström M, Hörlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK 1995 Polarity-specific activities of retinoic acid receptors determined by a co-repressor Nature 377:451454.
  • 165
    Rowland-Goldsmith MA, Henry HL, 1997 Structure and regulatory elements of the vitamin D down-regulated gene for cAMP dependent protein kinase inhibitor (PKI). In: NormanAW, BouillonR, ThomassetM, (eds.) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A. pp. 300301.
  • 166
    Forman BM, Umesono K, Chen J, Evans RM 1995 Unique response pathways are established by allosteric interactions among nuclear hormone receptors Cell 81:541550.
  • 167
    Chen J-Y, Clifford J, Zsui C, Starrett J, Tortolani D, Ostrowski J, Reczek PR, Chambon P, Gronemeyer H 1996 Two distinct actions of retinoid-receptor ligands Nature 382:819822.
  • 168
    Minucci S, Leid M, Toyama R, Saint-Jeannet J-P, Peterson VJ, Horn V, Ishmael JE, Bhattacharyya N, Dey A, Dawid IB, Ozato K 1997 Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependant gene expression Mol Cell Biol 17:644655.
  • 169
    Zugmaier G, Jäger R, Grage B, Gottardis MM, Havemann K, Knabbe C 1996 Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells Br J Cancer 73:13411346.
  • 170
    Kane KF, Langman MJS, Williams GR 1996 Antiproliferative responses of two human colon cancer cell lines to vitamin D3 are differentially modified by 9-cis-retinoic acid Cancer Res 56:623632.
  • 171
    Kang S, Xiao-Yan L, Duell EA, Voorhees J 1997 The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo J Invest Dermatol 108:513518.
  • 172
    Li XY, Xiao JH, Feng X, Qin L, Voorhees JJ 1997 Retinoid X receptor-specific ligands synergistically upregulate 1,25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo J Invest Dermatol 108:506512.
  • 173
    Blutt SE, Allegretto EA, Pike JW, Weigel NL 1997 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1 Endocrinology 138:14911497.
  • 174
    Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W 1993 Two nuclear signalling pathways for vitamin D Nature 361:657660.
  • 175
    Lemon BD, Freedman LP 1996 Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo Mol Cell Biol 16:10061016.
  • 176
    Zou A, Elgort MG, Allegretto EA 1997 Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3 J Biol Chem 272:1902719034.
  • 177
    Guo B, Aslam F, Van Wijnen A, Roberts SGE, Frenkel B, Green MR, DeLuca H, Lian JB, Stein GS, Stein J 1997 YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene Proc Natl Acad Sci USA 94:121126.
  • 178
    Liu M, Freedman LP 1994 Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors Mol Endocrinol 8:15931604.
  • 179
    Candeliere GA, Jurutka PW, Haussler MR, St-Arnaud R 1996 A composite element binding the vitamin D receptor, retinoid X receptor α, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter Mol Cell Biol 16:584592.
  • 180
    Krause KH, Michalak M 1997 Calreticulin Cell 88:439443.
  • 181
    Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors Nature 377:454457.
  • 182
    Perlmann T, Evans RM 1997 Nuclear receptors in Sicily: All in the famiglia Cell 90:391397.
  • 183
    Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L 1996 Nuclear receptor coactivators and corepressors Mol Endocrinol 10:11671177.
  • 184
    Edmondson DG, Roth SY 1996 Chromatin and transcription FASEB J 10:11731182.
  • 185
    Makino Y, Yamano K, Kanemaki M, Morikawa K, Kishimoto T, Shimbara N, Tanaka K, Tamura T 1997 SUG1, a component of the 26 S proteasome, is an ATPase stimulated by specific RNAs J Biol Chem 272:2320123205.
  • 186
    Masuyama H, Dowd DR, Brown AJ, MacDonald PN 1997 Proteasome-mediated degradation of the vitamin D receptor (VDR) and the potential involvement of a 1,25-(OH)2D3–dependent interaction between the VDR AF-2 domain and SUG1 J Bone Miner Res 12(Suppl. 1):S122 (abstract 79).
  • 187
    vom Baur E, Zechel C, Heery D, Heine MJS, Garnier JM, Vivat V, Chambon P, Losson R 1996 Differential ligand–dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1 EMBO J 15:110124.
  • 188
    Lemon BD, Fondell JD, Freedman LP 1997 Retinoid X receptor:vitamin D3 receptor heterodimers promote stable preinitiation complex formation and direct 1,25-dihydroxyvitamin D3-dependent cell-free transcription Mol Cell Biol 17:19231937.
  • 189
    Brown AJ, Dusso A, Slatopolsky E 1994 Selective vitamin D analogs and their therapeutic applications Sem Nephrol 14:156174.
  • 190
    Bouillon R, Okamura WH, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system Endocr Rev 16:200257.
  • 191
    Peleg S, Sastry M, Collins ED, Bishop JE, Norman AW 1995 Distinct conformational changes induced by 20-epi analogues of 1α,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor J Biol Chem 270:1055110558.
  • 192
    Abe J, Takita Y, Nakano T, Miyaura C, Suda T, Nishii Y 1989 A synthetic analogue of vitamin D3, 22-oxa-1α,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice Endocrinology 124:26452647.
  • 193
    Brown AJ, Ritter CS, Finch JL, Morrissey J, Martin KJ, Murayama E, Nishii Y, Slatopolsky E 1989 The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion J Clin Invest 84:728732.
  • 194
    Cheskis B, Lemon BD, Uskokovic M, Lomedico PT, Freedman LP 1995 Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3 Mol Endocrinol 9:18141824.
  • 195
    Reichrath J, Muller SM, Kerber A, Baum HP, Bahmer FA 1997 Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin J Am Acad Dermatol 36:1928.
  • 196
    Mehta RG, Moriarty RM, Mehta RR, Penmasta R, Lazzaro G, Constantinou A, Guo L 1997 Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1α-hydroxyvitamin D5 J Natl Cancer Inst 89:212218.
  • 197
    van den Bemd GC, Pols HA, Birkenhäger JC, van Leeuwen JP 1996 Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060 Proc Natl Acad Sci USA 93:1068510690.
  • 198
    Liu YY, Collins ED, Norman AW, Peleg S 1997 Differential interaction of 1alpha,25-dihydroxyvitamin D3 analogues and their 20-epi homologues with the vitamin D receptor J Biol Chem 272:33363345.
  • 199
    Zhao XY, Eccleshall TR, Krishnan AV, Gross C, Feldman D 1997 Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system Mol Endocrinol 11:366378.
  • 200
    Ishizuka S, Miura D, Manabe K, Gao Q, Sakuma Y, Uno H, Ozono K 1997 Novel 1α,25-dihydroxyvitamin D3-26,23-lactone analogues function as antagonists of vitamin D receptor-mediated genomic actions of 1α,25-dihydroxyvitamin D3 J Bone Miner Res 12(Suppl 1):S452 (abstract S399).
  • 201
    Ozono K, Ito M, Miura D, Ishizuka S, Yanagihara I, Nakajima S 1997 Novel 1α,25-dihydroxyvitamin D3 analogue, TEI-9647, acts as an antagonist of the vitamin D receptor J Bone Miner Res 12(Suppl 1):S122 (abstract 78).
  • 202
    Reichel H, Koeffler HP, Tobler A, Norman AW 1987 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes Proc Natl Acad Sci USA 84:33853389.
  • 203
    Barna M, Bos JD, Kapsenberg ML, Snijdewint FG 1997 Effect of calcitriol on the production of T-cell-derived cytokines in psoriasis Br J Dermatol 136:536541.
  • 204
    Johnson JA, Grande JP, Windebank AJ, Kumar R 1996 1,25-dihydroxyvitamin D3 receptors in developing dorsal root ganglia of fetal rats Brain Res Dev Brain Res 92:120124.
  • 205
    Musiol IM, Feldman D 1997 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: Effect of vitamin D3 analogs Endocrinology 116:149156.
  • 206
    Rizk-Rabin M, Zineb R, Zhor B, Michele G, Jana P 1994 Synthesis of and response to 1,25 dihydroxycholecalciferol by subpopulations of murine epidermal keratinocytes: Existence of a paracrine system for 1,25 dihydroxycholecalciferol J Cell Physiol 159:131141.
  • 207
    Reichrath J, Schilli M, Kerber A, Bahmer FA, Czarnetzki BM, Paus R 1994 Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle Br J Dermatol 131:477482.
  • 208
    Johnson JA, Grande JP, Roche PC, Kumar R 1996 Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues Histochem Cell Biol 105:715.
  • 209
    Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D 1994 Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells Cancer Res 54:805810.
  • 210
    Giuliano AR, Franceschi RT, Wood RJ 1991 Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: Effect of cellular differentiation Arch Biochem Biophys 285:261269.
  • 211
    Bikle DD, Pillai S 1993 Vitamin D, calcium and epidermal differentiation Endocr Rev 14:319.
  • 212
    Limat A, Hunziker T, Braathen LR 1993 Effects of 1 alpha,25-dihydroxy-vitamin D3 and calcipotriol on organotypic cultures of outer root sheath cells: A potential model to evaluate antipsoriatic drugs Arch Dermatol Res 285:402409.
  • 213
    Narvaez CJ, Welsh J 1997 Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant Endocrinology 138:46904698.
  • 214
    Thomas MG, Tebbutt S, Williamson RCN 1992 Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line Gut 33:16601663.
  • 215
    Nguyen TM, Guillozo H, Marin L, Tordet C, Koite S, Garabedian M 1996 Evidence for a vitamin D paracrine system regulating maturation of developing rat lung epithelium Am J Physiol 271:L392L399.
  • 216
    Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF 1979 Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid Science 206:11881190.
  • 217
    Johnson JA, Grande JP, Roche PC, Kumar R 1994 Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas Am J Physiol 267:E356E360.
  • 218
    Atley LM, Lefroy N, Wark JD 1995 1,25-dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells J Endocrinol 147:397404.
  • 219
    Berg JP, Liane KM, Bjorhovde SB, Bjoro T, Torjesen PA, Haug E 1994 Vitamin D receptor binding and biological effects of cholecalciferol analogues in rat thyroid cells J Steroid Biochem Mol Biol 50:145150.
  • 220
    Dokoh S, Donaldson CA, Marion SL, Pike JW, Haussler MR 1983 The ovary: A target organ for 1,25-dihydroxyvitamin D3 Endocrinology 112:200206.
  • 221
    Bidmon HJ, Gutkowska J, Murakami R, Stumpf WE 1991 Vitamin D receptors in heart: Effects on atrial natriuretic factor Experientia 47:958962.
  • 222
    Li Q, Gardner DG 1994 Negative regulation of the human atrial natriuretic peptide gene by 1,25-dihydroxyvitamin D3 J Biol Chem 269:49344939.
  • 223
    Wu J, Garami M, Cheng T, Gardner DG 1996 1,25(OH)2 Vitamin D3 and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes J Clin Invest 97:15771588.
  • 224
    Kawada T, Kamei Y, Sugimoto E 1996 The possibility of active form of vitamins A and D as suppressors on adipocyte development via ligand-dependent transcriptional regulators Int J Obes Relat Metab Disord 20(Suppl 3):S52S57.
  • 225
    Vu D, Ong JM, Clemens TL, Kern PA 1996 1,25-dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation Endocrinology 137:15401544.
  • 226
    Hedlund TE, Moffatt KA, Miller GJ 1996 Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: Evidence that the antiproliferative effects of 1α,25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway Endocrinology 137:15541561.
  • 227
    Yabushita H, Hirata M, Noguchi M, Nakanishi M 1996 Vitamin D receptor in endometrial carcinoma and the differentiation-inducing effect of 1,25-dihydroxyvitamin D3 on endometrial carcinoma cell lines J Obstet Gynaecol Res 22:529539.
  • 228
    Liu M, Lee MH, Bommakanti M, Freedman LP 1996 Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937 Genes Dev 10:142153.
  • 229
    Kawa S, Nikaido T, Aoki Y, Zhai Y, Kumagai T, Furihata K, Fujii S, Kiyosawa K 1997 Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines Br J Cancer 76:884889.
  • 230
    Rots NY, Freedman LP, 1997 Induction of myeloid cell differentiation by overexpression of different direct target genes of the 1α,25(OH)2D3 receptor. In: NormanAW, BouillonR, ThomassetM, (eds.) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A., pp. 423424.
  • 231
    Elstner E, Linker-Israeli M, Umiel T, Le J, Grillier I, Said J, Shintaku IP, Krajewski S, Reed JC, Binderup L, Koeffler HP 1996 Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells Cancer Res 56:35703576.
  • 232
    Simboli-Campbell M, Narvaez CJ, van Weelden K, Tenniswood M, Welsh J 1997 Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells Breast Cancer Res Treat 42:3141.
  • 233
    DeMay MB, Gerardi JM, DeLuca HF, Kronenberg HM 1990 DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3 Proc Natl Acad Sci USA 87:369373.
  • 234
    Markose ER, Stein JL, Stein GS, Lian JB 1990 Vitamin D-mediated modifications in protein–DNA interactions at two promoter elements of the osteocalcin gene Proc Natl Acad Sci USA 87:17011705.
  • 235
    Terpening CM, Haussler CA, Jurutka PW, Galligan MA, Komm BS, Haussler MR 1991 The vitamin D-responsive element in the rat bone gla protein is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxyvitamin D3-mediated transcriptional activation Mol Endocrinol 5:373385.
  • 236
    Kerner SA, Scott RA, Pike JW 1989 Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3 Proc Natl Acad Sci USA 86:44554459.
  • 237
    Morrison NA, Shine J, Fragonas J-C, Verkest V, McMenemy L, Eisman JA 1989 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene Science 246:11581161.
  • 238
    Ozono K, Liao J, Kerner SA, Scott RA, Pike JW 1990 The vitamin D-responsive element in the human osteocalcin gene: Association with a nuclear proto-oncogene enhancer J Biol Chem 265:2188121888.
  • 239
    Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, Denhardt DT 1990 Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Spp–1 or osteopontin) gene expression Proc Natl Acad Sci USA 87:99959999.
  • 240
    Cao X, Ross FP, Zhang L, MacDonald PN, Chappel J, Teitelbaum SL 1993 Cloning of the promoter for the avian integrin β3 subunit gene and its regulation by 1,25-dihydroxyvitamin D3 J Biol Chem 268:2737127380.
  • 241
    Jurutka PW, Hsieh J-C, Haussler MR 1994 Characterization of a new functional 1,25-dihydroxyvitamin D3 responsive element in the promoter region of the rat 25-hydroxyvitamin D3 24-hydroxylase gene J Bone Miner Res 9(Suppl 1):S160 (abstract 157).
  • 242
    Zierold C, Darwish HM, DeLuca HF 1994 Identification of a vitamin D-responsive element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene Proc Natl Acad Sci USA 91:900902.
  • 243
    Gill RK, Christakos S 1993 Identification of sequence elements in mouse calbindin-D28K gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses Proc Natl Acad Sci USA 90:29842988.
  • 244
    Liu SM, Koszewski N, Lupez M, Malluche HH, Olivera A, Russell J 1996 Characterization of a response element in the 5′-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor Mol Endocrinol 10:206215.
  • 245
    Kim RH, Li JJ, Ogata Y, Yamauchi M, Freedman LP, Sodek J 1996 Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene Biochem J 318:219226.
  • 246
    Falzon M 1996 DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression Mol Endocrinol 10:672681.
  • 247
    Kremer R, Sebag M, Champigny C, Meerovitch K, Hendy GN, White J, Goltzman D 1996 Identification and characterization of 1,25-dihydroxyvitamin D3-responsive repressor sequences in the rat parathyroid hormone-related peptide gene J Biol Chem 271:1631016316.
  • 248
    Tsonis PA, Sargent MT, Del Rio-Tsonis K, Jung JC 1996 9-cis retinoic acid antagonizes the stimulatory effect of 1,25 dihydroxyvitamin D3 on chrondrogenesis of chick limb bud mesenchymal cells: Interactions of their receptors Int J Dev Biol 40:10531059.
  • 249
    Cheskis B, Freedman LP 1994 Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers Mol Cell Biol 14:33293338.
  • 250
    Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR, 1998 Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis retinoic acid: Evidence for allosteric receptor interactions. J Biol Chem (in press).
  • 251
    Nakajima H, Kizaki M, Ueno H, Muto A, Takayama N, Matsushita H, Sonoda A, Ikeda Y 1996 All-trans and 9-cis retinoic acid enhance differentiation of U937 cells Leuk Res 20:665676.
  • 252
    Defacque H, Dornand J, Commes T, Cabane S, Sevilla C, Marti J 1994 Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines J Pharmacol Exp Ther 271:193199.
  • 253
    Bunce CM, Wallington LA, Harrison P, Williams GR, Brown G 1995 Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25-dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis Leukemia 9:410418.
  • 254
    James SY, Mackay AG, Colston KW 1995 Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells J Mol Endocrinol 14:391394.
  • 255
    Kato S, Sasaki H, Suzawa M, Masushige S, Tora L, Chambon P, Gronemeyer H 1995 Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors Mol Cell Biol 15:58585867.
  • 256
    Kephart DD, Walfish PG, DeLuca H, Butt TR 1996 Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast Mol Endocrinol 10:408419.
  • 257
    Schräder M, Nayeri S, Kahlen J-P, Müller KM, Carlberg C 1995 Natural vitamin D3 response elements formed by inverted palindromes: Polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation Mol Cell Biol 15:11541161.
  • 258
    Sneddon WB, Bogado CE, Kiernan MS, Demay MB 1997 DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation Mol Endocrinol 11:210217.
  • 259
    Ohyama Y, Ozono K, Uchida M, Yoshimura M, Shinki T, Suda T, Yamamoto O 1996 Functional assessment of two vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene J Biol Chem 271:3038130385.
  • 260
    Wheeler DG, Horsford J, Michalak M, White JH, Hendy GN 1995 Calreticulin inhibits vitamin D3 signal transduction Nucleic Acids Res 23:32683274.
  • 261
    Kim YS, MacDonald PN, Dedhar S, Hruska KA 1996 Association of 1α,25-dihydroxyvitamin D3-occupied vitamin D receptors with cellular membrane acceptance sites Endocrinology 137:36493658.
  • 262
    Imai T, Matsuda K, Shimojima T, Hashimoto T, Masuhiro Y, Kitamoto Sugita A, Suzuiki K, Matsumoto H, Masushige S, Nogi Y, Muramatsu M, Handa H, Kato S 1997 ERC-55, a binding protein for the papilloma virus E6 oncoprotein, specifically interacts with vitamin D receptor among nuclear receptors Biochem Biophys Res Commun 233:765769.
  • 263
    Schulman IG, Juguilon H, Evans RM 1996 Activation and repression by nuclear hormone receptors: Hormone modulates an equilibrium between active and repressive states Mol Cell Biol 16:38073813.
  • 264
    MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC Jr, DeLisle RK 1995 The vitamin D receptor interacts with general transcription factor IIB J Biol Chem 270:47484752.
  • 265
    Hong H, Kohli K, Garabedian MJ, Stallcup MR 1997 GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors Mol Cell Biol 17:27352744.
  • 266
    Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM 1997 Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 Cell 90:569580.
  • 267
    Baudino TA, Kraichely DM, Jefcoat SC Jr, MacDonald PN, 1997 Isolation and characterization of NCoA-62, a novel coactivator protein involved in vitamin D-mediated transcription. In: NormanAW, BouillonR, ThomassetM, (eds.) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A., pp. 320321.
  • 268
    Nakajima S, Yanagihara I, Ozono K 1997 A 65-kilodalton nuclear protein binds to the human vitamin D receptor: A bacterial-expressed histidine-tagged receptor study Biochem Biophys Res Commun 232:806809.
  • 269
    Le Douarin B, Zechel C, Garnier J-M, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18 EMBO J 14:20202033.
  • 270
    May M, Mengus G, Lavigne A-C, Chambon P, Davidson I 1996 Human TAFII28 promotes transcriptional stimulation by activation function 2 of the retinoid X receptors EMBO J 15:30933104.
  • 271
    Blanco JCG, Wang I-M, Tsai SY, Tsai M-J, O'Malley BW, Jurutka PW, Haussler MR, Ozato K 1995 Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription Proc Natl Acad Sci USA 92:15351539.
  • 272
    Masuyama H, Jefcoat SCJ, MacDonald PN 1997 The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription Mol Endocrinol 11:218228.
  • 273
    Blanco JCG, Dey A, Leid M, Minucci S, Park B-K, Jurutka PW, Haussler MR, Ozato K 1996 Inhibition of ligand induced promoter occupancy in vivo by a dominant negative RXR Genes Cells 1:209221.